Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Etanercept biosimilar by Mabxience Holding for Autoimmune Disorders: Likelihood of Approval
Etanercept biosimilar is under clinical development by Mabxience Holding and currently in Phase I for Autoimmune Disorders. According to GlobalData,...
Etanercept biosimilar by Shilpa Biologicals for Rheumatoid Arthritis: Likelihood of Approval
Etanercept biosimilar is under clinical development by Shilpa Biologicals and currently in Phase I for Rheumatoid Arthritis. According to GlobalData,...
Etanercept biosimilar by Shilpa Biologicals for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
Etanercept biosimilar is under clinical development by Shilpa Biologicals and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According...